These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 12625337)

  • 1. The people vs patents.
    New Sci; 2002 Jul; 175(2351):3. PubMed ID: 12625337
    [No Abstract]   [Full Text] [Related]  

  • 2. Your money or your life.
    Westphal SP
    New Sci; 2002 Jul; 175(2351):28-33. PubMed ID: 12625339
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 4. Critics question BRCA2 patent decision in Europe.
    Steimle S
    J Natl Cancer Inst; 2005 Sep; 97(18):1326. PubMed ID: 16174851
    [No Abstract]   [Full Text] [Related]  

  • 5. Protect pharmaceutical innovation.
    Musselwhite LW; Andrews J
    Science; 2010 Jun; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
    [No Abstract]   [Full Text] [Related]  

  • 6. Universities should foster neglected-disease work.
    Chokshi DA
    Nature; 2005 May; 435(7039):143. PubMed ID: 15889064
    [No Abstract]   [Full Text] [Related]  

  • 7. Sitting up and taking notice.
    Nat Biotechnol; 2010 May; 28(5):381. PubMed ID: 20458284
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic patent singles out Jewish women.
    Abbott A
    Nature; 2005 Jul; 436(7047):12. PubMed ID: 16001030
    [No Abstract]   [Full Text] [Related]  

  • 9. Malta provides loophole for breast-cancer screen.
    Check E
    Nature; 2002 Oct; 419(6909):767. PubMed ID: 12397316
    [No Abstract]   [Full Text] [Related]  

  • 10. Patent reform in the US: what's at stake for pharmaceutical innovation?
    Yancey A; Stewart CN
    Expert Opin Ther Pat; 2010 May; 20(5):603-8. PubMed ID: 20402544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. University-industry collaboration. Last of the big-time spenders?
    Lawler A
    Science; 2003 Jan; 299(5605):330-3. PubMed ID: 12531991
    [No Abstract]   [Full Text] [Related]  

  • 12. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 13. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 14. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 15. Patents on breast cancer genes are illegal and stymie research, say scientists.
    Lenzer J
    BMJ; 2009 Nov; 339():b4899. PubMed ID: 19920010
    [No Abstract]   [Full Text] [Related]  

  • 16. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Predisposition to breast cancer: Europe closes its doors to Myriad Genetics (Salt Lake City)].
    Nau JY
    Rev Med Suisse; 2007 Oct; 3(128):2320. PubMed ID: 17985613
    [No Abstract]   [Full Text] [Related]  

  • 18. What's fueling the biotech engine-2007.
    Aggarwal S
    Nat Biotechnol; 2008 Nov; 26(11):1227-33. PubMed ID: 18997759
    [No Abstract]   [Full Text] [Related]  

  • 19. Maximizing exclusivity for drug products.
    French H
    Nat Rev Drug Discov; 2005 Sep; 4(9):709. PubMed ID: 16178117
    [No Abstract]   [Full Text] [Related]  

  • 20. Research funding. Prizes eyed to spur medical innovation.
    Travis J
    Science; 2008 Feb; 319(5864):713. PubMed ID: 18258868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.